ARCHIVES

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

This article is from The Cancer Letter archive.

Vol. 28 No. 24 | June 14, 2002

Download PDF Visit The Full Archive

Related Articles

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

ICCCR Participants Honor Cullen, Blast Tobacco Industry

March 15, 1991

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

April 15, 1983

NIH Scientists Engineer Mice That Get Burkitt’s Lymphoma.

October 20, 2000

NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells.

November 23, 2007

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008